About this trial
The objective is to test the efficacy of a laparotomy-assisted fetoscopic surgical approach to cover spina bifida spinal cord developmental defects using cryopreserved human umbilical cords (NEOX Cord 1K®) as a meningeal and skin patch.
Eligibility criteria
Qualifiers
Singleton pregnancy
Gestational age at screening is 19 to 25 5/7 weeks and gestational age at surgery is 22 to 25 6/7 weeks
Maternal age: 18 years and older
Body mass index ≤45 kg/m2 (pre-pregnancy)
Disqualifiers
Non-resident of the United States
Multifetal pregnancy
Poorly controlled insulin-dependent pregestational diabetes
Poorly controlled A2 diabetes mellitus (A2DM) insulin-dependent diabetes
Trial design
Treatments tested in this trial
- NEOX Cord 1K applied fetoscopically
Treatment groups
Sponsors and collaborators
The University of Texas Health Science Center, Houston
Lead sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator